Genetic modification of cells and organisms is now a very well established technology. There are a range of tools capable of achieving transfection with high-fidelity, ease and efficiency. The challenge has now moved to the characterisation of phenotype for the modified organism, with a particular technology gap existing in accessing single-cell, dynamic data for metabolic processes.
Dr. Menolascina’s laboratory at the University of Edinburgh is looking to recruit a Research Associate to work on the automatic (re)design of synthetic promoters for mammalian cells.
Dr Javier Escudero and Dr Hamed Azami from the Institute for Digital Communications (IDCOM), in collaboration with Dr Alberto Fernández (from the Laboratory of Cognitive and Computational Neuroscience, Spain) have received the prestigious Nightingale Award for the best paper published in 2017 in Medical & Biological Engineering & Computing.
This position is based in Gilmorehill Campus, University of Glasgow. The project is a collaboration between University of Glasgow and University of Edinburgh.
Many medicines are highly effective but face difficulties in clinical applications such as possessing poor water solubility, low stability, short blood circulation half-life, and high toxicity.
